ContractClinical Study Agreement • January 3rd, 2019
Contract Type FiledJanuary 3rd, 2019ANTHEM-HFrEF CLINICAL STUDY AGREEMENTInstitution and Investigator Agreement SMLOUVA O KLINICKÉ STUDII ANTHEM-HFrEFSmlouva s pracovištěm a zkoušejícím This Agreement, effective as of this day of , 2018 and with effect from the day of its publication in the contracts register (“Effective Date”), by and between LivaNova USA, Inc., a corporation organized under the laws of the State of Delaware with an office at 100 Cyberonics Blvd., Houston, TX 77058, United States of America, company ID no. 2145759, acting by: Bruce KenKnight, VP of Heart Failure (hereinafter "LivaNova USA" or “Sponsor”);Cardiovascular Clinical Science Foundation, a non- profit corporation, together with its Affiliates, with offices at 75 Kneeland Street, Suite 702, Boston, MA 02111, United States of America, company ID no.4852204, represented by: Douglas Gregory, Chief Executive Officer (hereinafter “CCS’);Karma Oncology Limited, whose registered office is at 33 Kittoch Street, East Kilbride G74 4JW, Scotland, United Ki